MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01166nam a22002657i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250702132008.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250702s2020 ii a|||fr|||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789388902960 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-GaU |
| Transcribing agency |
EG-GaU |
| Modifying agency |
EG-GaU |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
635.1 |
| Item number |
B.P.D |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bigoniya, Papiya |
| Relator term |
author. |
| 9 (RLIN) |
60065 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Drug Regulatory Affairs / |
| Statement of responsibility, etc. |
Papiya Bigoniya. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New Delhi : |
| Name of producer, publisher, distributor, manufacturer |
CBS Publishers & Distributors Pvt Ltd, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
390 pages : |
| Other physical details |
illustration ; |
| Dimensions |
23 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| Media type code |
n |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| Carrier type code |
nc |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
A concise and up‑to‑date guide covering essential aspects of drug regulatory affairs including development, approval, manufacturing, monitoring, and compliance with international guidelines, tailored for pharmacy students and professionals.:contentReference[oaicite:1]{index=1}<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug regulation. |
| 9 (RLIN) |
60066 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical regulation. |
| 9 (RLIN) |
60055 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Clinical trials |
| Form subdivision |
Regulation. |
| 9 (RLIN) |
60067 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |